DaVita Inc. to Participate in Upcoming Investor Conferences
DaVita (NYSE: DVA) will participate in fireside chats at two upcoming healthcare investor conferences on November 9 and 10, 2026.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Summary
DaVita (NYSE: DVA) will participate in fireside chats at two upcoming healthcare investor conferences on November 9 and 10, 2026. Chief Financial Officer Joel Ackerman and Group Vice President of Investor Relations Nic Eliason will attend. The UBS Global Healthcare Conference chat is scheduled for November 9 at 1:15 pm EST; the Wolfe Research Healthcare Conference chat follows November 10 at 8:40 am EST.
Details
News Market Reaction – DVA
On Nov 4, the first trading day after this news, DVA closed 5.76% above the previous close. Our momentum scanner recorded 24 alerts for this stock that day.
Data tracked by StockTitan Argus for the Nov 4 session.
AI-generated analysis. How Rhea-AI works. Not financial advice.
UBS Global Healthcare Conference 2026
Date: Monday, November 9, 2026
Fireside Chat Presentation: 1:15 pm EST
To view the live webcast, visit the UBS conference page and create a free registration.
Wolfe Research Healthcare Conference 2026
Date: Tuesday, November 10, 2026
Fireside Chat Presentation: 8:40 am EST
To view the live webcast, visit the Wolfe conference page and create a free registration.
About DaVita Inc.
DaVita (NYSE: DVA) is a healthcare provider focused on transforming care delivery to improve quality of life for patients globally. As a comprehensive kidney care provider, DaVita has been a leader in clinical quality and innovation for 25 years. DaVita cares for patients at every stage and setting along their kidney health journey — from slowing the progression of kidney disease to helping support transplantation. This includes ensuring they are supported at home, in dialysis centers, in the hospital and in skilled nursing facilities. As of September 30, 2026, we provided dialysis services to a total of approximately 298,100 patients at 3,269 outpatient dialysis centers, of which 2,671 centers were located in the United States and 598 centers were located in 14 countries outside of the United States. DaVita has reduced hospitalizations, improved mortality, helped improve health access and worked collaboratively to propel the kidney care community to adopt a higher quality standard of care for all patients, everywhere. To learn more, visit DaVita.com/About.
Contact Information
IR@davita.com
View original content to download multimedia:https://www.prnewswire.com/news-releases/davita-inc-to-participate-in-upcoming-investor-conferences-302928240.html
SOURCE DaVita